General Information of Drug (ID: DM54XJO)

Drug Name
UMI-77
Synonyms
518303-20-3; C18H14BrNO5S2; MLS001196198; SMR000558497; 2-[4-[(4-bromophenyl)sulfonylamino]-1-hydroxynaphthalen-2-yl]sulfanylacetic acid; [(4-{[(4-bromophenyl)sulfonyl]amino}-1-hydroxy-2-naphthyl)thio]acetic acid; AC1LKK7D; UMI77; cid_992586; GTPL8105; SCHEMBL14842934; CHEMBL1331211; BDBM53290; EX-A762; AOB6936; MolPort-000-682-969; BCP09696; ZINC4149952; STK238370; 2780AH; s7531; AKOS001057042; SB19399; CS-5046; MCULE-2580729398; NCGC00386409-01; UMI-77, > HY-18628; DA-42224; BC600617; AK547843; EU-0015042
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C18H14BrNO5S2
Canonical SMILES
C1=CC=C2C(=C1)C(=CC(=C2O)SCC(=O)O)NS(=O)(=O)C3=CC=C(C=C3)Br
InChI
1S/C18H14BrNO5S2/c19-11-5-7-12(8-6-11)27(24,25)20-15-9-16(26-10-17(21)22)18(23)14-4-2-1-3-13(14)15/h1-9,20,23H,10H2,(H,21,22)
InChIKey
WUGANDSUVKXMEC-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
992586
TTD ID
D05RDP

References

1 A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo. Mol Cancer Ther. 2014 Mar;13(3):565-75.